Rhode Island Attorney General Peter Neronha joined a national coalition of attorneys last week announcing a $49.1 million ...
Two major pharmaceutical companies are paying a total of $49.1 million to resolve allegations they engaged in a “widespread, ...
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
Every Part D plan has changed its drug coverage for the coming year. There is no longer a “doughnut hole,” and the $2,000 cap ...
Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...
The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...
Seniors have until Dec. 7 to make a decision about their 2025 plans. Help is available to review premiums, deductibles and ...
This list can have an impact on your drug coverage in 2025 and shows why this open enrollment is so important.
Sick people in our country could lose access to essential medicines such as Paracetamol and Metformin (a basic treatment for ...